» Articles » PMID: 6704790

Etiology of Parkinson's Disease: A Research Strategy

Overview
Specialty Neurology
Date 1984 Feb 1
PMID 6704790
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

In this essay I present a new "global approach hypothesis" to explain the pathophysiology of Parkinson's disease: "Susceptibility to Parkinsonism is genetically determined and is reflected in all cells. I propose that idiopathic Parkinson's disease is the combined result of a generalized cell aging process accelerated, in susceptible individuals, by a variety of often repetitive trigger factors. These factors have in common the fact that they cause a transient increase in turnover within catecholamine producing neurons, centrally as well as peripherally. This results in accumulation within these neurons of free radicals. When the level of the toxic substances, in quantity or in time of exposure, exceeds the scavenging capacity of the cell, damage to organelles and to membranes results, leading to the formation of Lewy bodies through an autoimmune reaction to damaged filaments and to cell death, particularly in the pigmented neurons of the brainstem. The progressive cell depletion leads to a compensatory increase in catecholamine turnover in the remaining pigmented cells, and an ever-accelerating degenerative process. The resulting neurotransmitter imbalance in the basal ganglia explains the symptoms of Parkinson's disease". In the light of this hypothesis, our research objectives should be (1) to delineate the limits of true Parkinson's disease from all phenocopies; (2) to identify individuals susceptible to parkinsonism and the most common trigger factors; (3) to reduce the metabolic effects of unavoidable trigger factors and (4) to protect susceptible individuals by increasing the functional availability of free radical trapping agents.

Citing Articles

Longitudinal multi-omics in alpha-synuclein Drosophila model discriminates disease- from age-associated pathologies in Parkinson's disease.

Moore J, Wu T, Dhindsa J, El Fadel O, Le A, Perez A NPJ Parkinsons Dis. 2025; 11(1):46.

PMID: 40069190 PMC: 11897226. DOI: 10.1038/s41531-025-00899-z.


Case Report: Synucleinopathy Associated With Neurotoxicity in Sheep.

Tayebi M, Pinczowski P, Habiba U, Khan R, David M, Summers B Front Vet Sci. 2021; 8:736567.

PMID: 34722702 PMC: 8551671. DOI: 10.3389/fvets.2021.736567.


Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos.

Tayebi M, El-Hage C, Pinczowski P, Whiteley P, David M, Li Q Sci Rep. 2019; 9(1):16546.

PMID: 31723225 PMC: 6853926. DOI: 10.1038/s41598-019-53396-8.


The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Muller-Nedebock A, Brennan R, Venter M, Pienaar I, van der Westhuizen F, Elson J Neurochem Int. 2019; 129:104495.

PMID: 31233840 PMC: 6702091. DOI: 10.1016/j.neuint.2019.104495.


Aging and Parkinson's disease: Different sides of the same coin?.

Collier T, Kanaan N, Kordower J Mov Disord. 2017; 32(7):983-990.

PMID: 28520211 PMC: 5844262. DOI: 10.1002/mds.27037.